Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cv Sciences Inc (OP: CVSI )

0.0330 +0.0020 (+6.45%)
Streaming Delayed Price Updated: 3:48 PM EDT, Aug 8, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 393,706
Open 0.0310
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0310
Today's Range 0.0300 - 0.0335
52wk Range 0.0300 - 0.3649
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Marijuana As An Appetite Suppressant? It's A Possibility
Using cannabis as an appetite suppressant for weight management may seem counterintuitive, but one rare cannabinoid may have just that effect. Delta-9 (d-9)-dominant tetrahydrocannabivarin (THCV) has... 
Via Benzinga
CV Sciences Q1 Revenue Down 8.33%, CEO Encouraged As PlusCBD Brand Gains Market Share
CV Sciences, Inc. (OTCQB: CVSI) released its financial results for the quarter ended March 31, 2022, revealing a revenue drop of 8.33% to $4.4 million YoY. First Quarter 2022 and Recent Financial and... 
Via Benzinga

Performance

YTD
-72.32%
-72.32%
1 Month
-1.79%
-1.79%
3 Month
-45.00%
-45.00%
6 Month
-75.74%
-75.74%
1 Year
-89.18%
-89.18%

More News

Read More
A Preview Of CV Sciences's Earnings
Via Benzinga
CV Sciences Adds +PlusCBD Relief Softgels To Wellness Line Of CBD Products
Via Benzinga
Dry January Got You Down? Cannabis To The Rescue With Tokes, Yummy Gummies And More
Via Benzinga
CV Sciences Launches +PlusCBD Pain Relief Topicals With Products For Athletes, Arthritis Patients
Via Benzinga
Nutrition Giant GNC To Distribute CBD Products In 770 Stores In US
Via Benzinga
Is Medical Marijuana Really A Slippery Slope? CVSI Distribution Agreement with GNC
Via Benzinga
The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More
Via Benzinga
Topics Cannabis
Exposures Cannabis
Trending Up: $TLLTF $VRNOF $UNRV, GOP Cannabis Bill, Cause for Hope? — Cannabis Daily November 16, 2021
Via Benzinga
Topics Cannabis
Exposures Cannabis
CV Sciences 3Q Financials Continue To Improve Cost Structure, Praises California CBD Legislation
Via Benzinga
Topics Supply Chain
Exposures Supply Chain
Pharmaceutical & Hemp Wellness Segments Of Cannabidiol Market Could See the Fastest Growth Rates Through 2028
Via FinancialNewsMedia
Earnings Preview For CV Sciences
Via Benzinga
EXCLUSIVE: CV Sciences Launches New Product Line Featuring Full Range Of Phytocannabinoids
Via Benzinga
Looking Into CV Sciences's Return On Capital Employed
Via Benzinga
Ryder Cup To Retirees: Many Golfers Say CBD Is A Hole In One For Their Game
Via Benzinga
Cantor Remains Neutral on Charlotte's Web, cbdMD and CV Science CBD Stocks, Sector Could Benefit From Federal Legalization
Via Benzinga
American Cannabis Operator Index Lost 0.6% This Year, Best Players In July: Columbia Care, Lowell Farms, Ayr Wellness & Ascend Wellness
Via Benzinga
Topics Cannabis
Exposures Cannabis
Slight Correction For Cannabis Stocks After A Ramping Week, Check Out The Top Movers For July 30, 2021
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Week In Cannabis: Amazon Lobbies In DC, Colombia's New Law, Big IPOs And More
Via Benzinga
Topics Cannabis
Exposures Cannabis
Watch Planet 13's CEO & Matt Hawkins From Entourage Effect Capital At Benzinga Cannabis Hour 7/21
Via Benzinga
Topics Cannabis
Exposures Cannabis
CBD Can Reduce Nicotine Withdrawal Symptoms, Says New Study Done By CV Sciences
Via Benzinga
Australis, CV Sciences And MedMen Among Top Cannabis Stock Movers On July 9, 2021
Via Benzinga
Topics Cannabis
Exposures Cannabis
Watch CV Sciences & Lyphe Group On The Benzinga Cannabis Hour
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From June 21, 2021
Via Benzinga
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.